Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

2.
3.
5.

Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.

Tabor E.

Princess Takamatsu Symp. 1995;25:151-61. Review.

PMID:
8875620
6.

Genes and viruses in hepatobiliary neoplasia.

Reeves ME, DeMatteo RP.

Semin Surg Oncol. 2000 Sep-Oct;19(2):84-93. Review.

PMID:
11126384
7.

Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.

Lin Y, Shi CY, Li B, Soo BH, Mohammed-Ali S, Wee A, Oon CJ, Mack PO, Chan SH.

Ann Acad Med Singapore. 1996 Jan;25(1):22-30. Review.

PMID:
8779541
8.

The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.

Marotta F, Vangieri B, Cecere A, Gattoni A.

Clin Ter. 2004 May;155(5):187-99. Review.

PMID:
15344567
9.

Hepatocellular carcinoma: an update.

Dominguez-Malagón H, Gaytan-Graham S.

Ultrastruct Pathol. 2001 Nov-Dec;25(6):497-516. Review.

PMID:
11783914
10.
11.

[Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].

Xue KX.

Ai Zheng. 2005 Jun;24(6):757-68. Review. Chinese.

PMID:
15946497
12.

Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr mice.

Sipowicz MA, Weghorst CM, Shiao YH, Buzard GS, Calvert RJ, Anver MR, Anderson LM, Rice JM.

Carcinogenesis. 1997 Jan;18(1):233-6.

PMID:
9054612
13.

Functional inactivation but not structural mutation of p53 causes liver cancer.

Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G.

Nat Genet. 1995 Jan;9(1):41-7.

PMID:
7704023
14.

Hepatitis B virus infection, the immune response and hepatocellular carcinoma.

Milich DR, Jones J, Hughes J, Maruyama T.

Ciba Found Symp. 1994;187:113-29; discussion 129-31. Review.

PMID:
7796667
15.

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.

Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, Harris CC.

Carcinogenesis. 1993 May;14(5):987-92.

PMID:
8389256
16.

Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.

Kim MY, Park E, Park JH, Park DH, Moon WS, Cho BH, Shin HS, Kim DG.

Oncogene. 2001 Jul 27;20(33):4568-75.

17.

Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.

Kasai Y, Takeda S, Takagi H.

Semin Surg Oncol. 1996 May-Jun;12(3):155-9. Review.

PMID:
8727603
18.

p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis.

Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S.

Cancer Res. 1994 Jan 1;54(1):231-5.

19.

Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.

Pascale RM, Simile MM, Feo F.

Anticancer Res. 1993 Sep-Oct;13(5A):1341-56. Review.

PMID:
8239505
20.

Elevated expression of hepatic proliferative markers during early hepatocarcinogenesis in hepatitis-B virus transgenic mice lacking mdr1a-encoded P-glycoprotein.

Bao JJ, Lee BP, Stephens LC, Sahin AA, Van NT, Johnston DA, Ou CN, Kuo MT.

Mol Carcinog. 2000 Oct;29(2):103-11.

PMID:
11074607

Supplemental Content

Support Center